Global /Taiwan /Healthcare /Drug Manufacturers - General /1777

SYN-TECH Chem. & Pharm. Co., Ltd.

1777

• TPEX: 1777 • Delayed

70.90TWD 0%

2.25 USD

As of 6 June 2026, SYN-TECH Chem. & Pharm. Co., Ltd. has a market cap of $100.5M USD, ranking #25525 globally and #1383 in Taiwan. It ranks #2289 in the Healthcare sector, and #830 in the Drug Manufacturers - General industry.

Global Rank

25525

Country Rank

1383

Sector Rank

2289

Industry Rank

830

Key Stats

Market Cap

$100.5MUSD

3.16B TWD

Enterprise Value

$72.97MUSD

2.3B TWD

Revenue (TTM)

$41.33MUSD

1.3B TWD

EBITDA (TTM)

$14.74MUSD

463.83M TWD

Net Income (TTM)

$8.32MUSD

261.61M TWD

EBITDA Margin

36%

Profit Margin

20%

PE Ratio

12.1

PS Ratio

2.4

PB Ratio

1.2

EV/EBITDA

4.9

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

223

Founded

1982

Website

syn-tech.com.tw open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	0.8%	-1.7%	-1.9%	-7.4%	-3.9%	-22%	-26%	-29%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	1777 生泰合成工業股份有限公司 ISIN: TW0001777001 Shares Out.: Shares Outstanding: 44.592M¹ Shares Float: 31.836M² TV: TradingView: TPEX: 1777 SA: Stock Analysis: TPEX: 1777 YF: Yahoo Finance: 1777.TWO GF: Google Finance: TPEX: 1777 BA: Barron's: 1777 MS: Morningstar: ROCO: 1777	70.90 TWD	TV: TradingView: TPEX: 1777 SA: Stock Analysis: TPEX: 1777 YF: Yahoo Finance: 1777.TWO GF: Google Finance: TPEX: 1777 BA: Barron's: 1777 MS: Morningstar: ROCO: 1777

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About SYN-TECH Chem. & Pharm. Co., Ltd.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, anti-ulcerative, antihypertensive, α-blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anesthetic, decongestant, antispasmodic, neuroprotective, antimigraine, pharmaceutic aid/lubricant, antiglaucoma agent, hyponatremia, antidepressant, sedative, and analgesic, as well as treatment for hyperparathyroidism and urinary frequency, benign prostatic hypertrophy, and Herpes virus helicase-primase inhibitor. SYN-TECH Chem. & Pharm. Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.

Similar Companies

Industry: Drug Manufacturers - General (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
PharmaEssentia Corp. TWSE: 6446	$7.8B 245.34B TWD 8K%	48.6	Taiwan
Lotus Pharmaceutical Co., Ltd. TWSE: 1795	$1.84B 57.95B TWD 2K%	12.2	Taiwan
Center Laboratories, Inc. TPEX: 4123	$925.55M 29.11B TWD 821%	3.4	Taiwan
Lumosa Therapeutics Co., Ltd. TPEX: 6535	$809.3M 25.46B TWD 705%	-	Taiwan
Oneness Biotech Co., Ltd. TPEX: 4743	$789.12M 24.82B TWD 685%	-	Taiwan
TTY Biopharm Company Ltd. TPEX: 4105	$584.14M 18.38B TWD 481%	11.8	Taiwan

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 758K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 544K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 359K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 323K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 288K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 276K%	20.5	Switzerland

chevron_leftBack